3Ridker JM, Charles GM, Julie EB, et al. C-reactive protein and markers of inflammation in prediction of cardiovascular risk in women.N Engl J Med, 2000,342:826-843.
4Shah S, Newby K. C-reactive protein: a novel marker of cardiovascular risk.Cardiol Rev, 2003,11:169-179.
5Ridker PM, Hermekens CH, Roitman- Johrkson B et al.Plasma concentration of soluble intercellular adhesion molecule I and risks of future myocardial infarction in apparently healthy men. Lancet, 1998; 351:88-92.
6Haim M, Tanne D, Boyko V et al. Soluble intercellular adhesion molecule-1 and long- term risk of acute coronary events in patients with chronic heart disease. Data from the Bezafibrate Infarction Prevention Study. J Am Coil Cardiol,2002; 39:1133-1138.
7Ridker PM, Buring JE, Rifai N, Soluble P-selectin and the risk of future cardiovascular events. Circulation, 2001; 103:491-495.
8Malik I, Danesh J, Whincup Pet al. Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and mata-analysis. Lancet, 2001; 358: 971-976.
9Ridker PM, Rifai N, Pfeffer Met al. Elevation of tumor necrosis factor-alpha and increase risk of recurrent coronary events after myocardial infarction. Circulation, 2000; 101:2149-2153.
10Rider PM, Rifai N, Stampfer MJ et al. Hasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation,2000;101:1767-1772.
